Skip to search formSkip to main contentSkip to account menu

WT1 peptide vaccine

Known as: WT-1 vax, WT1 Analog Peptide Vaccine 
A peptide vaccine comprised of an epitope of human Wilms tumor 1 (WT-1) with potential antineoplastic activity. WT-1, a transcription factor, is… 
National Institutes of Health

Related topics

Related topics

4 relations
Antigen SensitizationCytotoxic T-LymphocytesT-Cell Activationimmunopotentiation

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
DSP-7888, a Novel Cocktail Design of WT1 Peptide Vaccine, and Its Combinational Immunotherapy with Immune Checkpoint-Blocking Antibody Against PD-1
Background: Wilms9 tumor gene 1 (WT1), broadly expressed in hematological malignancies and solid tumors, is a promising candidate… 
2012
2012
Enhanced tumor immunity of WT1 peptide vaccination by interferon-β administration.
2006
2006
Clinical and immune responses of WT1-peptide vaccination in patients with acute myeloid leukemia.
2511 Background: The transcription factor Wilms tumor protein (WT) 1 belongs to a new generation of tumor antigens, as it is… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)